48 results
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
, before expenses, to us
Underwriting discounts and commissions do not include the reimbursement of certain expenses of the underwriter we have agreed
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
and commissions do not include the reimbursement of certain expenses of the underwriter we have agreed to pay. See “Underwriting” for a description
8-K
EX-10.1
vdzhtqaejfbs8it7rfkz
1 May 23
Departure of Directors or Certain Officers
7:30am
S-3
8qk4p 6ze
23 Dec 22
Shelf registration
4:16pm
8-K
EX-1.1
9j3 67d1oex91s5
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
424B4
k6lmdox76 391d0queb
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
tbnj3g9p4e5atclk
20 Oct 22
Draft registration statement
12:00am